Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. University Hospitals of Cleveland, Cleveland, Ohio, United States



Survival: ?
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs: Adriamycin
Taxotere
Country: United States
   
City/State/Province: Cleveland, Ohio
   
Hospital: University Hospitals of Cleveland
   
Journal: Link
   
Date: 12/2005

Description:
Patients: This Phase II study involved 39 women with inoperable or large operable metastatic breast cancer. The median age was 47 years.

Treatment: The treatment consisted of two chemotherapeutic agents: docetaxel and doxorubicin. Patients thereafter underwent surgery as determined by their physicians.

Toxicity: Grade 3-4 toxicities included neutropenia, mucositis, fatigue, pain, and hand-foot syndrome.

Results: The median overall survival was not reported as 88% of patients survived after 70 months after the start of treatment. The authors concluded, "Primary chemotherapy with dose-dense doxorubicin and docetaxel given sequentially is well tolerated and allows a high rate of breast sparing in patients with large breast cancers."

Support: Aventis Pharmaceuticals financially supported this study. Aventis manufactures and/or markets docetaxel.

Correspondence: Brenda W. Cooper

E-mail to a Friend Email Physician More Information